Palo Alto Investors LP Astrazeneca PLC Transaction History

Palo Alto Investors LP

  • $727 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$55.72 - $67.12 $1.63 Million - $1.96 Million
-29,260 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$54.02 - $63.83 $9.3 Million - $11 Million
-172,229 Reduced 85.48%
29,260 $1.7 Million
Q3 2021

Nov 15, 2021
BUY
$55.56 - $60.79 $11.2 Million - $12.2 Million
201,489 New
201,489 $12.1 Million

Others Institutions Holding AZN

# of Institutions
1,360
Shares Held
475M
Call Options Held
5.39M
Put Options Held
3.75M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Palo Alto Investors LP Portfolio

Follow Palo Alto Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Investors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email